Drug Shortage Report for APO-ROSUVASTATIN

Last updated on 2017-11-07 History
Report ID 18560
Drug Identification Number 02338009
Brand name APO-ROSUVASTATIN
Common or Proper name ROSUVASTATIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) ROSUVASTATIN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL & 500 BTL & 30 BLS
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-08-07
Estimated end date 2017-11-30
Actual end date 2017-11-06
Shortage status Resolved
Updated date 2017-11-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2017-11-07 French Compare
v11 2017-11-07 English Compare
v10 2017-10-17 French Compare
v9 2017-10-17 English Compare
v8 2017-10-12 French Compare
v7 2017-10-12 English Compare
v6 2017-09-27 French Compare
v5 2017-09-27 English Compare
v4 2017-09-05 French Compare
v3 2017-09-05 English Compare
v2 2017-08-08 French Compare
v1 2017-08-08 English Compare

Showing 1 to 12 of 12